TTK Healthcare (TTKHLTCARE.NS) Stock Price

TTK Healthcare Price

CLOSED
1,005.00
​
Market closed

Over the last 19 years TTK Healthcare grew revenue by 7.7% annually, reaching 8.57 B INR. Earnings per share have grown at 17.6% per year over the last 19 years. For TTK Healthcare, the net margin of 7.7% is broadly stable versus 6.9% a few years ago. At today's price the dividend yield works out to roughly 1.00%. The payout ratio is around 14% of earnings. The dividend has grown at 6.8% per year over the past 16 years.

TTK Healthcare stock price

Access this data via the Eulerpool API

TTK Healthcare business model & stock analysis

TTK Healthcare Ltd. engages in the provision of consumer products. The company is headquartered in Chennai, Tamil Nadu and currently employs 1,294 full-time employees. The company went IPO on 2010-01-08. The Company’s segments include Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, Others and Human Pharma. The Animal Welfare segment includes products for veterinary use. The Consumer products comprise marketing and distribution of Eva range of cosmetics, Woodward’s gripe water, good home range of scrubbers, air fresheners and others. The Medical Devices segment comprises manufacturing and marketing of artificial heart valves, orthopedic implants and others. The Protective Devices segment comprises manufacturing and marketing of male contraceptives and other allied products. The Foods segment comprises manufacturing and marketing of Food Products. The Others segment includes printing and publishing of maps and atlases. The Human Pharma segment includes products for human use. The company has approximately 30 product categories and services with 16 manufacturing units.

Frequently asked questions about TTK Healthcare

7 analysts currently rate the TTK Healthcare stock: 6 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the TTK Healthcare share trades at 9.27 EUR (1,005.00 INR).

The revenue of TTK Healthcare is 8.57 B INR. This figure is based on current financial data and reflects the company's business performance.

The profit of TTK Healthcare is 656.81 M INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of TTK Healthcare is currently 21.62. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the TTK Healthcare stock.

The price-to-sales ratio (P/S) of TTK Healthcare is currently 1.66. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the TTK Healthcare stock.

The Eulerpool Quality Score for TTK Healthcare is 4/10.

The ISIN of TTK Healthcare is INE910C01018. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of TTK Healthcare is TTKHLTCARE.NS. The ticker symbol is used to trade TTK Healthcare shares on the stock exchange.

Fair ValueTerminal
1,005.00 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
6.63 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Jan 8, 2010
ISIN
INE910C01018
Cusip
Y8998T106
Market capitalization
14.20 B INRLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
69.92
P/B Ratio
1.27
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
5.77 %
Dividend
Dividend yield
1.00 %
Payout Ratio
14.00 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
16 years
Dividend not reduced since
5 years
Dividend increased since
0 years
Dividend withholding tax
20.00 %
Last updated Oct 9, 2026, 9:29 PM

TTK Healthcare Peer Group

TTK Healthcare FIGI

TTKP:IN · BBG000D0VB50TTKP:IB · BBG000D0WD64TTKP:IS · BBG000D0WF23TTKP:IG · BBG003NVY118